Article citationsMore>>

Zanni, P.C.M.D., Bonfim-Mendonça, P.d.S., Negri, M., Nakamura, S.S., Donatti, L., Svidzinski, T.I.E., et al. (2017) Virulence Factors and Genetic Variability of Vaginal Candida Albicans Isolates from HIV-Infected Women in the Post-Highly Active Antiretroviral Era. Revista do Instituto de Medicina Tropical de São Paulo, 59, 1-10.
https://doi.org/10.1590/s1678-9946201759044

has been cited by the following article:

• TITLE: Targeting Candida albicans Biofilms: Antibiofilm Efficacy of Hemibastadin Alkaloids Analogues

  AUTHORS: Alain Kacou, Ange Désiré Yapi, Estelle Kone, Déto Jean Paul Ursul N’Guessan, Songuigama Coulibaly, Etienne Angora, Henriette Vanga, Hervé Menan, Mahama Ouattara, Yves Blache

  KEYWORDS: Hemibastadin, 1, 2, 3-Triazole, Candida albicans, Biofilm, Antibiofilm

  JOURNAL NAME: Advances in Biological Chemistry, Vol.16 No.2, March 17, 2026

  ABSTRACT: Antibiofilm activity of four hemibastadin analogues was evaluated against a clinical Candida albicans strain. Three of four analogues demonstrated significant antibiofilm effects, with EC50 values of 34.4 ± 9.6 µM for the most efficient. This most active compounds notably reduced both the biovolume and thickness of the biofilm. Importantly, antifungal susceptibility testing confirmed that the observed effects were specific to biofilm inhibition and not due to general antifungal activity. These results, comparable to those obtained with biofilms of marine Gram-negative bacteria, highlight the potential of hemibastadin analogues as promising lead compounds for the development of broad-spectrum antibiofilm including Candida albicans without exerting selective pressure for antimicrobial resistance.